A carregar...
Pharmacological eEF2K activation promotes cell death and inhibits cancer progression
Activation of the elongation factor 2 kinase (eEF2K) leads to the phosphorylation and inhibition of the elongation factor eEF2, reducing mRNA translation rates. Emerging evidence indicates that the regulation of factors involved in protein synthesis may be critical for controlling diverse biological...
Na minha lista:
| Publicado no: | EMBO Rep |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5048377/ https://ncbi.nlm.nih.gov/pubmed/27572820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embr.201642194 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|